Food and Drug Policy Forum

FDLI's Food and Drug Policy Forum provides a marketplace for the exchange of policy ideas regarding food and drug law issues, and is complimentary to all FDLI Members. Policy Forum articles are on cutting-edge state, national and international policy issues related to food and drug law.


The Policy Forum is published biweekly (24 times a year) and is provided as a complimentary benefit to FDLI members, and by subscription to non-members. Individual issues of the Policy Forum are also available for separate purchase.



Food and Drug Policy Forum

Post-Market Drug Regulation in the Age of Big Data: What Path to the Promised Land?

November 2014

Issue 10 of the FDLI Food and Drug Policy Forum, entitled “Post-Market Drug Regulation in the Age of Big Data: What Path to the Pro...

A Natural Solution: Why Should FDA Define “Natural” Foods?

September 2014

Issue 9 of the FDLI Policy Forum, entitled “A Natural Solution: Why Should FDA Define “Natural” Foods?” focuses o...

Biosimilar Nomenclature: Can we Achieve the Truth, the Whole Truth, & Nothing but the Truth?

September 2014

Issue 8 of the FDLI Policy Forum, written by Peter Pitts, focuses on biosimilar nomenclature and recommends that FDA require differential...

The GRAS Exemption and GRAS Notification: Is There a Need for Significant Changes to Current Policy?

August 2014

Volume 4 Issue 7 of the FDLI Policy Forum – GRAS Issue 7 of the FDLI Policy Forum focuses on the generally recognized as safe (GRAS...

E-cigarettes: A life-saving technology or a way for tobacco companies to re-normalize smoking in American Society?

July 2014

This issue of Policy Forum, written by Joel Nitzkin, focuses on e-cigarettes and recommend adding a tobacco harm reduction component to t...

Additional Policy Forum Details

The Policy Forum welcomes articles on cutting-edge state, national and international policy issues related to food and drug law. FDLI's Food and Drug Policy Forum is designed to provide a venue for the presentation of information, analysis and policy recommendations in the following areas: food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

Each peer-reviewed issue of the Policy Forum presents an important policy topic in the form of a question, provides background information and detailed discussion of the issues involved in that policy question, details the relevant research, cites pertinent sources, and then makes policy recommendations.

The 23-member Food and Drug Policy Forum Editorial Advisory Board, comprised of 9 leading associations and 14 individuals involved in food and drug law issues, provides peer review and guidance on articles considered for publication in the Forum.

  • Center for Medicine in the Public Interest
  • Drug Information Association
  • Environmental Working Group
  • Food Marketing Institute
  • Medical Device Manufacturers Association
  • The Pew Charitable Trusts
  • PhRMA
  • Plasma Protein Therapeutics Association
  • United Fresh Produce Association